Shandong Weigao Group Medical Polymer CoSHWGY +6.90%70 Return-on-Tangible-Equity is 6.33% as of Dec. 2025, which is 56% below its 10-year median of 14.26. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.01 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Shandong Weigao Group Medical Polymer Co ranks better than 61.61% on this metric.
SHWGY'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.53 Med: 14.26 Max: 19.4
Current: 8.53
During the past 13 years, Shandong Weigao Group Medical Polymer Co's highest Return-on-Tangible-Equity was 19.40%. The lowest was 8.53%. And the median was 14.26%.
SHWGY's Return-on-Tangible-Equity is ranked better than 61.61% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs SHWGY: 8.53
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Shandong Weigao Group Medical Polymer Co Return-on-Tangible-Equity Related Terms
Shandong Weigao Group Medical Polymer Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co Return-on-Tangible-Equity Chart
Shandong Weigao Group Medical Polymer Co Annual Data
SHWGY vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 6.33% mean?
Shandong Weigao Group Medical Polymer Co (SHWGY) has a Return-on-Tangible-Equity of 6.33% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. This is 56% below median its historical median of 14.26. Over the past decade, Shandong Weigao Group Medical Polymer Co's Return-on-Tangible-Equity has ranged from 8.53 to 19.40. According to the industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #291 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 38.4%.
Is Shandong Weigao Group Medical Polymer Co's Return-on-Tangible-Equity too high?
Shandong Weigao Group Medical Polymer Co's current Return-on-Tangible-Equity of 6.33% is 56% below median its 10-year median of 14.26. Over the past 10 years, this metric has ranged from a low of 8.53 to a high of 19.40. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.08. Shandong Weigao Group Medical Polymer Co's value of 6.33% is 55.1% above this industry median. Based on the distribution chart, Shandong Weigao Group Medical Polymer Co ranks #291 out of 758 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #291 out of 758 companies for Return-on-Tangible-Equity. This puts Shandong Weigao Group Medical Polymer Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.08. Shandong Weigao Group Medical Polymer Co's value of 6.33% is 55.1% above this benchmark. Historically, Shandong Weigao Group Medical Polymer Co's own Return-on-Tangible-Equity has ranged from 8.53 to 19.40 over the past decade. While the company's 10-year median is 14.26 vs. the industry median of 4.08, Shandong Weigao Group Medical Polymer Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Group Medical Polymer Co's current Return-on-Tangible-Equity of 6.33% is 55.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Group Medical Polymer Co's current Return-on-Tangible-Equity is 6.33%, which is 56% below median its own 10-year median of 14.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.01, compared to a current price of $1.60 — trading 47% below its estimated fair value. The current Return-on-Tangible-Equity is 6.33%, which is 56% below median its 10-year median of 14.26 and 55.1% above the Medical Devices & Instruments industry median of 4.08. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current Return-on-Tangible-Equity is 6.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of $1.60 is trading 47% below its estimated GF Value™ of $3.01.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for SHWGY:
Return-on-Tangible-Equity: 6.33% (56% below median its 10-year median of 14.26)
GF Value™: $3.01 vs. price of $1.60 (47% below fair value)
Industry Position: 55.1% above the Medical Devices & Instruments median (#291 of 758)
No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score
Get the complete analysis for SHWGY
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWGY has been successfully added to your 
